Gilead Sciences (GILD) Exchange Rate Effect (2009 - 2026)
Gilead Sciences (GILD) reported Exchange Rate Effect of -$11.0 million for Q1 2026, down 157.89% on a YoY basis from $19.0 million in Q1 2025, and down 320.0% quarter-over-quarter from $5.0 million in Q4 2025.
Gilead Sciences (GILD) Exchange Rate Effect (2009 - 2026) Analysis & Trends
Gilead Sciences has reported Exchange Rate Effect for 18 years, with the latest figure at -$11.0 million in Q1 2026.
- For the quarter ending Q1 2026, Exchange Rate Effect fell 157.89% year-over-year to -$11.0 million; the trailing twelve-month figure through Mar 2026 stood at $62.0 million (up 2166.67% YoY), and the FY2025 full-year result was $92.0 million, up 330.0% from the prior year.
- Exchange Rate Effect for Q1 2026 stood at -$11.0 million, down from $5.0 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $75.0 million in Q4 2022, with the low at -$72.0 million in Q3 2022.
- Historically, Exchange Rate Effect has averaged $2.1 million across 5 years, with a median of -$5.0 million in 2025.
- The largest YoY upside for Exchange Rate Effect was 933.33% in 2022 against a maximum downside of 340.0% in 2022.
- Gilead Sciences' Exchange Rate Effect stood at $75.0 million in 2022, then sank by 50.67% to $37.0 million in 2023, then tumbled by 248.65% to -$55.0 million in 2024, then jumped by 109.09% to $5.0 million in 2025, then sank by 320.0% to -$11.0 million in 2026.
- The last three Exchange Rate Effect figures came in at -$11.0 million (Q1 2026), $5.0 million (Q4 2025), and -$5.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | 2.70 Mn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | 67.00 Mn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | -25.00 Mn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | -12.00 Mn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | -19.00 Mn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | -11.00 Mn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | 19.00 Mn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | -48.00 Mn |
| 10 | Novartis Ag | 108.28 Bn | 107.60 Bn | - | -77.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.00 Mn |
| Mar 31, 2026 | -11.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Dec 31, 2025 | 5.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Jun 30, 2025 | 73.00 Mn |
| Jun 30, 2025 | 73.00 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Mar 31, 2025 | 19.00 Mn |
| Dec 31, 2024 | -55.00 Mn |
| Dec 31, 2024 | -55.00 Mn |
| Sep 30, 2024 | 44.00 Mn |
| Sep 30, 2024 | 44.00 Mn |
| Jun 30, 2024 | -11.00 Mn |
| Jun 30, 2024 | -11.00 Mn |
| Mar 31, 2024 | -18.00 Mn |
| Mar 31, 2024 | -18.00 Mn |
| Dec 31, 2023 | 37.00 Mn |
| Dec 31, 2023 | 37.00 Mn |